المؤلفون: Shah VT; Director of Cardiology, Surana Sethia Hospital, Mumbai, Maharashtra, India, Corresponding Author.

المصدر: The Journal of the Association of Physicians of India [J Assoc Physicians India] 2024 Sep; Vol. 72 (9), pp. 64-72.

نوع المنشور: Journal Article; Observational Study

بيانات الدورية: Publisher: Association of Physicians of India Country of Publication: India NLM ID: 7505585 Publication Model: Print Cited Medium: Print ISSN: 0004-5772 (Print) Linking ISSN: 00045772 NLM ISO Abbreviation: J Assoc Physicians India Subsets: MEDLINE

مواضيع طبية MeSH: Ezetimibe*/therapeutic use , Hydroxymethylglutaryl-CoA Reductase Inhibitors*/therapeutic use , Hydroxymethylglutaryl-CoA Reductase Inhibitors*/administration & dosage , Cholesterol, LDL*/blood , Anticholesteremic Agents*/therapeutic use , Anticholesteremic Agents*/administration & dosage, Humans ; Cross-Sectional Studies ; Male ; India ; Retrospective Studies ; Middle Aged ; Female ; Atorvastatin/therapeutic use ; Drug Therapy, Combination ; Aged ; Rosuvastatin Calcium/therapeutic use ; Rosuvastatin Calcium/administration & dosage

المؤلفون: Kim Y; Division of Cardiology, Department of Internal Medicine, Yonsei University College of Medicine and Cardiovascular Center, Yongin Severance Hospital, Yongin, Korea., Roh JW; Division of Cardiology, Department of Internal Medicine, Yonsei University College of Medicine and Cardiovascular Center, Yongin Severance Hospital, Yongin, Korea., Lee OH; Division of Cardiology, Department of Internal Medicine, Yonsei University College of Medicine and Cardiovascular Center, Yongin Severance Hospital, Yongin, Korea., Heo SJ; Division of Biostatistics, Department of Biomedical Systems Informatics, Yonsei University College of Medicine, Seoul, Korea., Im E; Division of Cardiology, Department of Internal Medicine, Yonsei University College of Medicine and Cardiovascular Center, Yongin Severance Hospital, Yongin, Korea., Cho DK; Division of Cardiology, Department of Internal Medicine, Yonsei University College of Medicine and Cardiovascular Center, Yongin Severance Hospital, Yongin, Korea., Kim BK; Division of Cardiology, Department of Internal Medicine, Severance Cardiovascular Hospital, Yonsei University College of Medicine, Seoul, Korea.

المصدر: The Korean journal of internal medicine [Korean J Intern Med] 2024 Sep; Vol. 39 (5), pp. 793-800. Date of Electronic Publication: 2024 Jun 24.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Korean Association of Internal Medicine Country of Publication: Korea (South) NLM ID: 8712418 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2005-6648 (Electronic) Linking ISSN: 12263303 NLM ISO Abbreviation: Korean J Intern Med Subsets: MEDLINE

مواضيع طبية MeSH: Antibodies, Monoclonal, Humanized*/administration & dosage , Cholesterol, LDL*/blood , Anticholesteremic Agents*/administration & dosage , Anticholesteremic Agents*/adverse effects , Percutaneous Coronary Intervention* , Myocardial Infarction*/drug therapy , Myocardial Infarction*/blood , Myocardial Infarction*/diagnosis, Humans ; Retrospective Studies ; Male ; Female ; Middle Aged ; Aged ; Treatment Outcome ; Time Factors ; Biomarkers/blood ; Dyslipidemias/drug therapy ; Dyslipidemias/blood ; Dyslipidemias/diagnosis ; PCSK9 Inhibitors ; Proprotein Convertase 9

المؤلفون: Cashmore B; Sydney School of Public Health, The University of Sydney, Sydney, New South Wales, Australia.; Centre for Kidney Research, The Children's Hospital of Westmead, Sydney, New South Wales, Australia., Tunnicliffe DJ; Sydney School of Public Health, The University of Sydney, Sydney, New South Wales, Australia.; Centre for Kidney Research, The Children's Hospital of Westmead, Sydney, New South Wales, Australia., Palmer S; Department of Medicine, University of Otago Christchurch, Christchurch, New Zealand., Blythen L; Consumer Partner, Australia., Boag J; Consumer Partner, Australia.; School of Health, Federation University, Ballarat, Victoria, Australia., Kostner K; Mater Hospital, University of Queensland, St Lucia, Queensland, Australia., Krishnasamy R; Department of Nephrology, Sunshine Coast University Hospital, Birtinya, Queensland, Australia.; Centre for Kidney Disease Research, The University of Queensland, Brisbane, Queensland, Australia.; Australasian Kidney Trials Network, The University of Queensland, Brisbane, Queensland, Australia., Lambert K; Faculty of Science, Medicine and Health, University of Wollongong, Wollongong, New South Wales, Australia., Miller A; Cape York Kidney Care, Weipa Integrated Health Services, Weipa, Queensland, Australia., Mullan J; Faculty of Science, Medicine and Health, University of Wollongong, Wollongong, New South Wales, Australia., Patu M; Māori/Indigenous Health Institute, University of Otago, Christchurch, New Zealand., Phoon RKS; Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.; Department of Renal Medicine, Centre for Transplant and Renal Research, Westmead Hospital, Westmead, New South Wales, Australia., Rix L; Adelaide Nursing School, University of Adelaide, Adelaide, South Australia, Australia., Trompf N; Consumer Partner, Australia., Johnson DW; Australasian Kidney Trials Network, The University of Queensland, Brisbane, Queensland, Australia.; Department of Kidney and Transplant Services, Princess Alexandra Hospital, Woolloongabba, Queensland, Australia.; Translational Research Institute, Brisbane, Queensland, Australia., Walker R; Department of Medicine, University of Otago Dunedin, Dunedin, New Zealand.

مؤلفون مشاركون: CARI Guidelines Steering Committee

المصدر: Nephrology (Carlton, Vic.) [Nephrology (Carlton)] 2024 Aug; Vol. 29 (8), pp. 495-509. Date of Electronic Publication: 2024 Apr 29.

نوع المنشور: Journal Article; Practice Guideline

بيانات الدورية: Publisher: Blackwell Science Country of Publication: Australia NLM ID: 9615568 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1440-1797 (Electronic) Linking ISSN: 13205358 NLM ISO Abbreviation: Nephrology (Carlton) Subsets: MEDLINE

مواضيع طبية MeSH: Anticholesteremic Agents*/therapeutic use , Anticholesteremic Agents*/adverse effects , Hydroxymethylglutaryl-CoA Reductase Inhibitors*/therapeutic use , Renal Insufficiency, Chronic*/drug therapy , Renal Insufficiency, Chronic*/complications, Humans ; Australia/epidemiology ; Cardiovascular Diseases/prevention & control ; Cardiovascular Diseases/epidemiology ; Cardiovascular Diseases/etiology ; Ezetimibe/therapeutic use ; New Zealand/epidemiology ; Practice Guidelines as Topic ; Professional Practice Gaps

المؤلفون: Soleimani H; Cardiac Primary Prevention Research Center, Cardiovascular Diseases Research Institute, Tehran University of Medical Sciences, Tehran, Iran.; Tehran Heart Center, Cardiovascular Diseases Research Institute, Tehran University of Medical Sciences, Tehran, Iran., Mousavi A; Cardiac Primary Prevention Research Center, Cardiovascular Diseases Research Institute, Tehran University of Medical Sciences, Tehran, Iran.; Tehran Heart Center, Cardiovascular Diseases Research Institute, Tehran University of Medical Sciences, Tehran, Iran., Shojaei S; Cardiac Primary Prevention Research Center, Cardiovascular Diseases Research Institute, Tehran University of Medical Sciences, Tehran, Iran.; Tehran Heart Center, Cardiovascular Diseases Research Institute, Tehran University of Medical Sciences, Tehran, Iran., Tavakoli K; Cardiac Primary Prevention Research Center, Cardiovascular Diseases Research Institute, Tehran University of Medical Sciences, Tehran, Iran.; Tehran Heart Center, Cardiovascular Diseases Research Institute, Tehran University of Medical Sciences, Tehran, Iran., Salabat D; Cardiac Primary Prevention Research Center, Cardiovascular Diseases Research Institute, Tehran University of Medical Sciences, Tehran, Iran.; Tehran Heart Center, Cardiovascular Diseases Research Institute, Tehran University of Medical Sciences, Tehran, Iran., Farahani Rad F; Cardiac Primary Prevention Research Center, Cardiovascular Diseases Research Institute, Tehran University of Medical Sciences, Tehran, Iran.; Tehran Heart Center, Cardiovascular Diseases Research Institute, Tehran University of Medical Sciences, Tehran, Iran., Askari MK; Department of Medicine, University of Toledo, Toledo, Ohio, USA., Nelson J; California Cardiovascular Institute, University of Louisville School of Medicine, Fresno, California, USA., Ruzieh M; Division of Cardiovascular Medicine, College of Medicine, University of Florida, Gainsville, Florida, USA., Hosseini K; Cardiac Primary Prevention Research Center, Cardiovascular Diseases Research Institute, Tehran University of Medical Sciences, Tehran, Iran.; Tehran Heart Center, Cardiovascular Diseases Research Institute, Tehran University of Medical Sciences, Tehran, Iran.

المصدر: Clinical cardiology [Clin Cardiol] 2024 Aug; Vol. 47 (8), pp. e24334.

نوع المنشور: Systematic Review; Journal Article; Meta-Analysis; Review

بيانات الدورية: Publisher: John Wiley & Sons, Inc Country of Publication: United States NLM ID: 7903272 Publication Model: Print Cited Medium: Internet ISSN: 1932-8737 (Electronic) Linking ISSN: 01609289 NLM ISO Abbreviation: Clin Cardiol Subsets: MEDLINE

مواضيع طبية MeSH: Ezetimibe*/therapeutic use , Ezetimibe*/administration & dosage , Ezetimibe*/adverse effects , Hydroxymethylglutaryl-CoA Reductase Inhibitors*/therapeutic use , Hydroxymethylglutaryl-CoA Reductase Inhibitors*/administration & dosage , Hydroxymethylglutaryl-CoA Reductase Inhibitors*/adverse effects , Cholesterol, LDL*/blood , Drug Therapy, Combination* , Anticholesteremic Agents*/therapeutic use , Anticholesteremic Agents*/administration & dosage , Anticholesteremic Agents*/adverse effects, Humans ; Treatment Outcome ; Atherosclerosis/drug therapy ; Atherosclerosis/blood ; Biomarkers/blood

المؤلفون: Nicholls SJ; Victorian Heart Institute, Monash University, Victoria, Australia. Electronic address: stephen.nicholls@monash.edu., Nelson AJ; Victorian Heart Institute, Monash University, Victoria, Australia., Ditmarsch M; NewAmsterdam Pharma, Naarden, The Netherlands., Kastelein JJP; NewAmsterdam Pharma, Naarden, The Netherlands., Ballantyne CM; Baylor College of Medicine and the Texas Heart Institute, Houston, TX., Ray KK; Department of Primary Care and Public Health, Imperial College London, London, UK., Navar AM; University of Texas Southwestern Medical Center, Dallas, TX., Nissen SE; Cleveland Clinic Lerner School of Medicine at Case Western Reserve University, Cleveland, OH., Golberg AC; Washington University School of Medicine, St. Louis, MO., Brunham LR; UBC Centre for Heart Lung Innovation, The University of British Columbia, Vancouver, British Columbia, Canada., Curcio D; NewAmsterdam Pharma, Naarden, The Netherlands., Wuerdeman E; NewAmsterdam Pharma, Naarden, The Netherlands., Neild A; NewAmsterdam Pharma, Naarden, The Netherlands., Kling D; NewAmsterdam Pharma, Naarden, The Netherlands., Hsieh A; NewAmsterdam Pharma, Naarden, The Netherlands., Dicklin MR; Midwest Biomedical Research, Addison, IL., Ference BA; Centre for Naturally Randomized Trials, University of Cambridge, Cambridge, UK., Laufs U; Klinik und Poliklinkk für Kardiologie, Leipzig University, Germany., Banach M; Department of Preventive Cardiology and Lipidologym, Medical University of Lodz (MUL), Lodz, Poland., Mehran R; The Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, NY., Catapano AL; IRCCS MultiMedica, Milan, Italy; Department of Pharmacological and Biomolecular Sciences, University of Milan, Milan, Italy., Davidson MH; NewAmsterdam Pharma, Naarden, The Netherlands.

المصدر: American heart journal [Am Heart J] 2024 Aug; Vol. 274, pp. 32-45. Date of Electronic Publication: 2024 May 04.

نوع المنشور: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase III; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Mosby Country of Publication: United States NLM ID: 0370465 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-6744 (Electronic) Linking ISSN: 00028703 NLM ISO Abbreviation: Am Heart J Subsets: MEDLINE

مواضيع طبية MeSH: Atherosclerosis*/drug therapy , Atherosclerosis*/prevention & control , Anticholesteremic Agents*/therapeutic use , Anticholesteremic Agents*/administration & dosage , Cholesterol, LDL*/blood, Humans ; Double-Blind Method ; Male ; Female ; Cholesterol Ester Transfer Proteins/antagonists & inhibitors ; Cholesterol, HDL/blood ; Hyperlipoproteinemia Type II/drug therapy ; Hyperlipoproteinemia Type II/blood ; Hyperlipoproteinemia Type II/complications ; Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use ; Lipoprotein(a)/blood ; Middle Aged

المؤلفون: Lütjohann D, Stellaard F

المصدر: International journal of clinical pharmacology and therapeutics [Int J Clin Pharmacol Ther] 2024 Jul; Vol. 62 (7), pp. 295-306.

نوع المنشور: Journal Article; Randomized Controlled Trial

بيانات الدورية: Publisher: Dustri-Verlag Dr. K. Feistle Country of Publication: Germany NLM ID: 9423309 Publication Model: Print Cited Medium: Print ISSN: 0946-1965 (Print) Linking ISSN: 09461965 NLM ISO Abbreviation: Int J Clin Pharmacol Ther Subsets: MEDLINE

مواضيع طبية MeSH: Cholesterol, LDL*/blood , Simvastatin*/pharmacology , Simvastatin*/therapeutic use , Anticholesteremic Agents*/pharmacology , Anticholesteremic Agents*/therapeutic use , Ezetimibe*/therapeutic use , Ezetimibe*/pharmacology , Cholesterol*/blood , Cholesterol*/biosynthesis , Hypercholesterolemia*/drug therapy , Hypercholesterolemia*/blood, Humans ; Male ; Adult ; Middle Aged ; Drug Therapy, Combination ; Intestinal Absorption/drug effects ; Hydroxymethylglutaryl-CoA Reductase Inhibitors/pharmacology ; Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use

المؤلفون: Sheng F; Medical Affairs, Amgen K.K., Wang AY; Center for Observational Research, Amgen Australia., Miyawaki K; Medical Affairs, Amgen K.K., Tsuchiya T; Medical Affairs, Amgen K.K., Osada N; Medical Affairs, Amgen K.K., Miller R; Syneos Health., Fu Z; Syneos Health., Okamura T; Department of Preventive Medicine and Public Health, Keio University School of Medicine.

المصدر: Circulation journal : official journal of the Japanese Circulation Society [Circ J] 2024 Sep 25; Vol. 88 (10), pp. 1629-1636. Date of Electronic Publication: 2024 Mar 01.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Japanese Circulation Society Country of Publication: Japan NLM ID: 101137683 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1347-4820 (Electronic) Linking ISSN: 13469843 NLM ISO Abbreviation: Circ J Subsets: MEDLINE

مواضيع طبية MeSH: Antibodies, Monoclonal, Humanized*/therapeutic use , PCSK9 Inhibitors* , Anticholesteremic Agents*/therapeutic use, Humans ; Japan/epidemiology ; Retrospective Studies ; Male ; Middle Aged ; Female ; Aged ; Databases, Factual ; Adult ; Hyperlipoproteinemia Type II/drug therapy ; Hyperlipoproteinemia Type II/epidemiology ; Hyperlipoproteinemia Type II/blood ; Ezetimibe/therapeutic use ; Proprotein Convertase 9

عنوان ترانسليتريتد: Livelli di colesterolo bassi e molto bassi: cosa è necessario sapere.

المؤلفون: Di Fusco SA; U.O.C. Cardiologia Clinica e Riabilitativa, Presidio Ospedaliero San Filippo Neri - ASL Roma 1, Roma., Leggio M; U.O.C. Cardiologia Clinica e Riabilitativa, Presidio Ospedaliero San Filippo Neri - ASL Roma 1, Roma., Gil Ad V; U.O. Cardiologia, Ospedale Policlinico San Martino, Genova., Giubilato S; U.O.C. Cardiologia con UTIC ed Emodinamica, Azienda Ospedaliera Cannizzaro, Catania., Aquilani S; U.O.C. Cardiologia Clinica e Riabilitativa, Presidio Ospedaliero San Filippo Neri - ASL Roma 1, Roma., Nardi F; Dipartimento di Cardiologia, Ospedale Santo Spirito, Casale Monferrato (AL)., Grimaldi M; U.O.C. Cardiologia-UTIC, Ospedale Miulli, Acquaviva delle Fonti (BA)., Gabrielli D; U.O.C. Cardiologia, Dipartimento Cardio-Toraco-Vascolare, Azienda Ospedaliera San Camillo Forlanini, Roma - Fondazione per il Tuo cuore - Heart Care Foundation, Firenze., Oliva F; Unità di Cure Intensive Cardiologiche, Cardiologia 1-Emodinamica, Dipartimento Cardiotoracovascolare 'A. De Gasperis', ASST Grande Ospedale Metropolitano Niguarda, Milano., Imperoli G; U.O.C. Medicina, Dipartimento di Emergenza e Accettazione, Presidio Ospedaliero San Filippo Neri - ASL Roma 1, Roma., Colivicchi F; U.O.C. Cardiologia Clinica e Riabilitativa, Presidio Ospedaliero San Filippo Neri - ASL Roma 1, Roma.

مؤلفون مشاركون: a nome dell’Area Prevenzione Cardiovascolare e dell’Area Management e Qualità ANMCO

المصدر: Giornale italiano di cardiologia (2006) [G Ital Cardiol (Rome)] 2024 Sep; Vol. 25 (9), pp. 650-659.

نوع المنشور: Journal Article; Review; English Abstract

بيانات الدورية: Publisher: Il Pensiero Scientifico Editore Country of Publication: Italy NLM ID: 101263411 Publication Model: Print Cited Medium: Internet ISSN: 1972-6481 (Electronic) Linking ISSN: 18276806 NLM ISO Abbreviation: G Ital Cardiol (Rome) Subsets: MEDLINE

مواضيع طبية MeSH: Anticholesteremic Agents*/therapeutic use , Cholesterol, LDL*/blood , Hypercholesterolemia*/blood , Hypercholesterolemia*/complications , Hypercholesterolemia*/drug therapy, Humans ; Cardiovascular Diseases/blood ; Cardiovascular Diseases/etiology ; Cardiovascular Diseases/prevention & control ; PCSK9 Inhibitors/therapeutic use ; Risk Assessment

المؤلفون: Xie S; Epidemiology and Preventive Pharmacology Service (SEFAP), Department of Pharmacological and Biomolecular Sciences, University of Milan, Milan, Italy., Galimberti F; IRCCS MultiMedica, Milan, Italy., Olmastroni E; Epidemiology and Preventive Pharmacology Service (SEFAP), Department of Pharmacological and Biomolecular Sciences, University of Milan, Milan, Italy.; IRCCS MultiMedica, Milan, Italy., Catapano AL; Epidemiology and Preventive Pharmacology Service (SEFAP), Department of Pharmacological and Biomolecular Sciences, University of Milan, Milan, Italy.; IRCCS MultiMedica, Milan, Italy., Casula M; Epidemiology and Preventive Pharmacology Service (SEFAP), Department of Pharmacological and Biomolecular Sciences, University of Milan, Milan, Italy.; IRCCS MultiMedica, Milan, Italy.

المصدر: Journal of internal medicine [J Intern Med] 2024 Sep; Vol. 296 (3), pp. 302-305. Date of Electronic Publication: 2024 Jul 11.

نوع المنشور: Meta-Analysis

بيانات الدورية: Publisher: Blackwell Scientific Publications Country of Publication: England NLM ID: 8904841 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2796 (Electronic) Linking ISSN: 09546820 NLM ISO Abbreviation: J Intern Med Subsets: MEDLINE

مواضيع طبية MeSH: Anticholesteremic Agents*/therapeutic use , C-Reactive Protein*/analysis , C-Reactive Protein*/metabolism , Hydroxymethylglutaryl-CoA Reductase Inhibitors*/therapeutic use, Humans ; Colchicine/therapeutic use ; Dicarboxylic Acids/therapeutic use ; Drug Therapy, Combination ; Ezetimibe/therapeutic use ; Network Meta-Analysis ; Fatty Acids/therapeutic use

المؤلفون: Brady AJB; Honorary Professor of Cardiology, University of Glasgow, Glasgow, United Kingdom; Consultant Cardiologist, Glasgow Royal Infirmary, Glasgow, United Kingdom. Electronic address: adrian.brady@glasgow.ac.uk.

المصدر: Mayo Clinic proceedings [Mayo Clin Proc] 2024 Aug; Vol. 99 (8), pp. 1204-1205.

نوع المنشور: Editorial

بيانات الدورية: Publisher: [Oxford, England] Country of Publication: England NLM ID: 0405543 Publication Model: Print Cited Medium: Internet ISSN: 1942-5546 (Electronic) Linking ISSN: 00256196 NLM ISO Abbreviation: Mayo Clin Proc Subsets: MEDLINE

مواضيع طبية MeSH: Anticholesteremic Agents*/therapeutic use, Humans ; Hypercholesterolemia/drug therapy ; Cholesterol/blood ; RNA, Small Interfering